Overview

Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in South Asian subjects with hypercholesterolemia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AstraZeneca
Treatments:
Atorvastatin
Atorvastatin Calcium
Rosuvastatin Calcium
Criteria
Inclusion Criteria:

- Fasting low density lipoprotein & triglyceride levels as defined by the protocol.

- Self described South Asian race

- Subjects with coronary heart disease or at high risk of coronary heart disease.

Exclusion Criteria:

- The use of lipid lowering drugs or dietary supplements after Visit 1.

- Active arterial disease eg Unstable angina, or recent arterial surgery

- Blood lipid levels above the limits defined in the protocol.

- Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse.